Roubaix Capital, LLC Treace Medical Concepts, Inc. Transaction History

Roubaix Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$11.48 - $15.86 $623,605 - $861,531	-54,321 Reduced 44.24%	68,464 $893,000
Q4 2023 Aug 01, 2024	BUY	$6.03 - $12.88 $327,555 - $699,654	54,321 Added 79.34%	122,785 $1.57 Million
Q4 2023 Feb 07, 2024	BUY	$6.03 - $12.88 $740,393 - $1.58 Million	122,785 New	122,785 $1.57 Million
Q2 2022 Aug 05, 2022	SELL	$12.93 - $20.29 $1.56 Million - $2.44 Million	-120,415 Reduced 46.8%	136,893 $1.96 Million
Q1 2022 Apr 19, 2022	SELL	$16.73 - $21.58 $809,932 - $1.04 Million	-48,412 Reduced 15.84%	257,308 $4.87 Million
Q4 2021 Jan 28, 2022	BUY	$15.48 - $26.52 $4.73 Million - $8.11 Million	305,720 New	305,720 $5.7 Million

129

39.5M

272K

261K

Ticker TMCI
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 55,403,300
Market Cap $300M
Description
Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...

Get notified when there are updates to the investment portfolio of Roubaix Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Roubaix Capital, LLC with notifications on news.